Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Genus plc

GENSFPNK
Healthcare
Biotechnology
$37.25
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Genus plc (GENSF) Stock Overview

Explore Genus plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.5B
P/E Ratio93.88
EPS (TTM)$0.39
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$39.84
3 Months$42.97
1 Year Target$34.96

GENSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genus plc (GENSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $34.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 93.88 and a market capitalization of 2.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
5.97%
6-Month Change
11.90%
Year-to-Date (YTD) Change
6.43%
1-Year Change
65.56%
3-Year Change
10.27%
5-Year Change
-49.83%
All-Time (Max) Change
1762.50%

Contact Information

44 1256 347 100
Matrix House, Basingstoke, NaN, RG21 4DZ

Company Facts

35,000 Employees
IPO DateSep 11, 2009
CountryGB
Actively Trading

Frequently Asked Questions